Showing results (2061-2070 of 4,555) with videos related to

Sort By:
Pageof 456
Drug Development and Industrial Pharmacy|March 5, 2014
Formulation and evaluation of gastroretentive floating drug delivery system of dipyridamoleHuiming Jiang, Rui Tian, Wenjing Hu, et al.
Drug Development and Industrial Pharmacy|March 22, 2014
New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatmentAngela Lopedota, Annalisa Cutrignelli, Nunzio Denora, et al.
Drug Development and Industrial Pharmacy|March 6, 2014
Novel oleic acid derivatives enhance buccal permeation of didanosineElizabeth Ojewole, Rahul Kalhapure, Krishnacharya Akamanchi, et al.
Drug Development and Industrial Pharmacy|March 1, 2014
Preface for buccal drug delivery theme issueJavier Octavio Morales, Jason Thomas McConville
Drug Development and Industrial Pharmacy|October 24, 2018
Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cellsSai Kiran S S Pindiprolu, Pavan Kumar Chintamaneni, Praveen T Krishnamurthy, et al.
Drug Development and Industrial Pharmacy|November 17, 2018
Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipientManali Patki, Ketankumar Patel
Drug Development and Industrial Pharmacy|November 17, 2018
Study on the transdermal penetration mechanism of ibuprofen nanoemulsionsLi Zhengguang, Huang Jie, Zhang Yong, et al.
Drug Development and Industrial Pharmacy|November 20, 2018
Encapsulation of S-nitrosoglutathione: a transcriptomic validationRamia Safar, Rémi Houlgatte, Alain Le Faou, et al.
Drug Development and Industrial Pharmacy|November 6, 2018
A comparison of drug substance predicted chemical stability with ICH compliant stability studiesH E Williams, J Bright, E Roddy, et al.
Drug Development and Industrial Pharmacy|November 6, 2018
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeysJ Scott Crowe, Kevin J Roberts, Timothy M Carlton, et al.
Pageof 456